• It’s harder than you think to spend down your 401(k) account in retirement
    Business
    MarketWatchyesterday

    It’s harder than you think to spend down your 401(k) account in retirement

    At a recent conference, retirement experts concluded that the lack of an easy drawdown mechanism in 401(k) plans was the major challenge facing the 401(k) system. In 2014, the Treasury Department and the IRS issued guidance that made longevity annuities accessible to 401(k) plans and that enabled target date funds to include annuity contracts either as a default or as a regular investment option. But individual plan sponsors feel under siege by lawsuits and see little payoff to being innovative. At the same time, Congress is unlikely to mandate that annuities be a part of 401(k) arrangements. So we are at a standstill. Millions of Americans — having been told that their retirement plans are automatic

  • Here's how rich you would be if you invested in Amazon at its IPO
    Business
    Business Insider23 hours ago

    Here's how rich you would be if you invested in Amazon at its IPO

    Shares of Amazon have come a long way since the company's 1997 initial public offering. Since then, Amazon shares have sky rocketed 48,197% from their May 15, 1997 debut of $18 a share. Before Amazon was the "Everything Store" it was an online book store

  • Cramer Remix: The truth about Apple ahead of its earnings report
    Business
    CNBC.com19 hours ago

    Cramer Remix: The truth about Apple ahead of its earnings report

    Upon the release of BioMarin's orphan drug Brineura, which made headlines for its $702,000-per-year price tag, chairman and CEO JJ Bienaimé said the system will have the final say on whether the sky-high price is fair. "Obviously, the system will have to determine that," he told Cramer on Friday. "I think, hopefully, ... if there is any kind of regulations coming around health care, that they will make sure that those regulations protect innovation and protect innovative biotech companies," Bienaimé said. Finally, Cramer spoke with AGCO Chairman, President and CEO Martin Richenhagen to understand more about how President Donald Trump's protectionist slant might affect the agricultural landscape.